4882 Perseus Proteomics Inc.ペルセウスプロテオミクスTSE Growth / Pharmaceuticals
0 posts
Perseus Proteomics Inc. stock fell on Nov 18: what happened
It closed at ¥110 on Nov 18 (−¥10.0, −8.33%), ranking #16 among the top losers of all stocks on the Tokyo Stock Exchange.
Disclosures around that day
- 11/19 15:302027年3月期 第2四半期決算説明会における質疑応答(要旨)
Changes are calculated from the closing prices this site collects daily; limit-up/down is an estimate based on the daily price limit. Please make your own investment decisions.
Perseus Proteomics Inc. (4882) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Perseus Proteomics Inc. (4882) Stock Price HistoryNear an all-time low
Perseus Proteomics Inc. closed at ¥101 on Nov 20, 2026, −29.9% over 1 month, −67.1% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥70,139 today (−29.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −29.9%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥101 | −10 | −9.01% |
| Nov 19 (Thu) | ¥111 | +1 | +0.91% |
| Nov 18 (Wed) | ¥110 | −10 | −8.33% |
| Nov 16 (Mon) | ¥120 | −6 | −4.76% |
| Nov 13 (Fri) | ¥126 | +1 | +0.80% |
| Nov 12 (Thu) | ¥125 | −3 | −2.34% |
| Nov 11 (Wed) | ¥128 | +2 | +1.59% |
| Nov 10 (Tue) | ¥126 | +3 | +2.44% |
| Nov 9 (Mon) | ¥123 | +5 | +4.24% |
| Nov 6 (Fri) | ¥118 | −16 | −11.94% |
If you had invested ¥100,000 3 months ago, it would be worth ¥68,243 today (−31.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −31.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥101 | −10 | −9.01% |
| Nov 19 (Thu) | ¥111 | +1 | +0.91% |
| Nov 18 (Wed) | ¥110 | −10 | −8.33% |
| Nov 16 (Mon) | ¥120 | −6 | −4.76% |
| Nov 13 (Fri) | ¥126 | +1 | +0.80% |
| Nov 12 (Thu) | ¥125 | −3 | −2.34% |
| Nov 11 (Wed) | ¥128 | +2 | +1.59% |
| Nov 10 (Tue) | ¥126 | +3 | +2.44% |
| Nov 9 (Mon) | ¥123 | +5 | +4.24% |
| Nov 6 (Fri) | ¥118 | −16 | −11.94% |
If you had invested ¥100,000 6 months ago, it would be worth ¥59,412 today (−40.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −40.6%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥101 | −28.9% |
| Oct 2026 | ¥142 | −15.0% |
| Sep 2026 | ¥167 | +16.0% |
| Aug 2026 | ¥144 | −0.7% |
| Jul 2026 | ¥145 | −8.8% |
| Jun 2026 | ¥159 | +2.6% |
| May 2026 | ¥155 | −27.6% |
If you had invested ¥100,000 1 year ago, it would be worth ¥32,899 today (−67.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −67.1%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥101 | −28.9% |
| Oct 2026 | ¥142 | −15.0% |
| Sep 2026 | ¥167 | +16.0% |
| Aug 2026 | ¥144 | −0.7% |
| Jul 2026 | ¥145 | −8.8% |
| Jun 2026 | ¥159 | +2.6% |
| May 2026 | ¥155 | −27.6% |
| Apr 2026 | ¥214 | −2.7% |
| Mar 2026 | ¥220 | −6.0% |
| Feb 2026 | ¥234 | −2.5% |
| Jan 2026 | ¥240 | +7.1% |
| Dec 2025 | ¥224 | −28.2% |
| Nov 2025 | ¥312 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥13,667 today (−86.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −86.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥101 | −54.9% |
| 2025 | ¥224 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥22,345 today (−77.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −77.7%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥101 | −54.9% |
| 2025 | ¥224 | ― |
If you had invested ¥100,000 in Jun 2021, it would be worth ¥12,547 today (−87.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.0%, while this stock moved −87.5%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥101 | −54.9% |
| 2025 | ¥224 | −60.1% |
| 2024 | ¥562 | −9.1% |
| 2023 | ¥618 | +96.8% |
| 2022 | ¥314 | −20.9% |
| 2021 | ¥397 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jun 2021). Please check the latest prices before trading.
Perseus Proteomics Inc. (4882) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Perseus Proteomics Inc. (4882)
Business overview
The company is a University of Tokyo–born biotech developing antibody drugs. Based on protein expression and antibody production technology developed at the university's Research Center for Advanced Science and Technology, it researches and develops treatments for cancer and other diseases. Its distinctive approach combines the hybridoma, phage display and single B-cell screening methods to create antibodies that can become medicines meeting medical needs.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 1.97x | Above the sector median of 1.86x (No. 41 from the lowest) |
|---|---|---|
| Market cap | ¥1.9 bn | No. 78 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥312 | 2025/11/28 |
|---|---|---|
| 52-week low | ¥101 | 11/20 |
| Current position | 0.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥101) |
| Year to date | -54.9% | No. 72 of 77 in the sector (best first) |
| 1 year | -67.1% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 losers | 3 times | Latest: 11/18 (No. 16) |
|---|
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/20 17:00第三者割当による第31回新株予約権(行使価額修正条項付)の発行及び新株予約権買取契約の締結に関するお知らせ
- 11/20 17:00資金調達に関するご説明
- 11/19 15:302027年3月期 第2四半期決算説明会における質疑応答(要旨)
- 11/17 15:302027年3月期 第2四半期決算説明会資料
- 11/13 15:30営業外収益、営業外費用及び特別損失の計上に関するお知らせ
- 11/13 15:302027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)
Filings from the past 12 months (6).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the Perseus Proteomics Inc. board
More Japanese stocks in English
- Modalis Therapeutics Corporation4883
- Kringle Pharma,Inc.4884
- MUROMACHI CHEMICALS INC.4885
- ASKA Pharmaceutical Holdings Co.,Ltd.4886
- SAWAI GROUP HOLDINGS Co.,Ltd.4887
- STELLA PHARMA CORPORATION4888
- Renascience Inc.4889
- iShares Yen Appreciation Focus ETF488A
- Tsubota Laboratory Incorporated4890
- TMS Co.,Ltd.4891
- Cyfuse Biomedical K.K.4892
- Noile-Immune Biotech Inc.4893